Cargando…

School Nutrition Program; Prevention of Obesity and Fatty Liver in Children

Detalles Bibliográficos
Autores principales:	Ardalan, Gelayol, Alavian, Seyed-Moayed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tehran University of Medical Sciences 2014
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339553/ https://www.ncbi.nlm.nih.gov/pubmed/25755851

Ejemplares similares

Acute Fatty Liver of Pregnancy: A Life-Threatening Condition Requiring a Life-Saving Approach
por: Gorginzadeh, Mansoureh, et al.
Publicado: (2016)

Prevention of Hepatitis A Virus Infection, Need to Vaccinate or Not?
por: Elizee, Pegah Karimi, et al.
Publicado: (2013)

Volatile Anesthetics in Ischemic Liver Injury: Enemy or Friend?
por: Mohseni, Masood, et al.
Publicado: (2014)

An Unbelievable Fact on “Dialysis Centers Without Hepatitis C Infection”
por: Alavian, Seyed Moayed
Publicado: (2014)

Occult Hepatitis B Virus Infection Among Hemodialysis Patients
por: Alavian, Seyed Moayed
Publicado: (2012)

Unthought-of Problems Regarding Hepatitis D Virus Infection
por: Alavian, Seyed Moayed
Publicado: (2010)

On the Occasion of the World Hepatitis Day: World Hepatitis Day and Our Achievements and Responsibilities in Iran
por: Alavian, Seyed Moayed
Publicado: (2012)

Sofosbuvir Has Come Out of the Magic Box
por: Alavian, Seyed Moayed
Publicado: (2013)

New globally faces of hepatitis B and C in the world
por: Alavian, Seyed-Moayed
Publicado: (2011)

Gender Differences in Healthy Ranges for Serum Alanine Aminotransferase Levels in Adolescence
por: Poustchi, Hossein, et al.
Publicado: (2011)

Liver Biopsy Versus Non-Invasive Tests in Determining Liver Disease Status
por: Alavian, Seyed Moayed
Publicado: (2015)

Risk factors of hepatitis B infection: Health policy makers should be aware of their importance in each community
por: Miri, Seyed Mohammad, et al.
Publicado: (2011)

Dilemma of HBsAg seroconversion in chronic hepatitis B infection: Dilemma of HBsAg in chronic HBV
por: Alavian, Seyed Moayed, et al.
Publicado: (2011)

Oral Conditions Might Cause Severe Outcomes in Patients With Viral Hepatitis Infection
por: Mahboobi, Nima, et al.
Publicado: (2014)

RNA Interference: A Promising Approach for the Treatment of Viral Hepatitis
por: Motavaf, Mahsa, et al.
Publicado: (2012)

IL28B polymorphism, Explanation for Different Responses to Therapy in Hepatitis C Patients
por: Sharafi, Heidar, et al.
Publicado: (2011)

Hepatitis C resistance to NS5A inhibitors: Is it going to be a problem?
por: Sharafi, Heidar, et al.
Publicado: (2018)

Diet Macronutrients Composition in Nonalcoholic Fatty Liver Disease: A Review on the Related Documents
por: Hashemi Kani, Ali, et al.
Publicado: (2014)

Lessons learned from past cholera epidemics, interventions which are needed today
por: Lankarani, Kamran B, et al.
Publicado: (2013)

Assessment of transient elastography (FibroScan) for diagnosis of fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis
por: Hashemi, Seyed-Abbas, et al.
Publicado: (2016)

Intravenous Drug Use and Hepatitis C Virus in Iran
por: Zobeiri, Mehdi, et al.
Publicado: (2012)

Understanding of Molecular Pain Medicine: Genetic Basis of Variation in Pain Sensation and Analgesia Response
por: Motavaf, Mahsa, et al.
Publicado: (2013)

Occult Hepatitis C Infection Should Be More Noticed With New Treatment Strategies
por: Rezaee Zavareh, Mohammad Saeid, et al.
Publicado: (2015)

Necessity for Hepatitis B Surface Antigen Screening in Pregnant Females in Iran
por: Alavian, Seyed Moayed, et al.
Publicado: (2016)

Herbal medicine and liver disease, for any conclusion we need to do more studies
por: Alavian, Seyed Moayed
Publicado: (2011)

Ginger Supplementation in Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
por: Rahimlou, Mehran, et al.
Publicado: (2016)

Investigating the impact of eight weeks of aerobic and resistance training on blood lipid profile in elderly with non-alcoholic fatty liver disease: a randomized clinical trial
por: Ghamarchehreh, Mohammad Ebrahim, et al.
Publicado: (2019)

Effect of Aerobic and Resistance Exercise Training on Liver Enzymes and Hepatic Fat in Iranian Men With Nonalcoholic Fatty Liver Disease
por: Shamsoddini, Alireza, et al.
Publicado: (2015)

Sofosbuvir vs. Combination of Pegylated Interferon and Ribavirin; How Much Shall Pay for Iranian Patients?
por: Pourhoseingholi, Mohamad Amin, et al.
Publicado: (2014)

Dietary Quality Indices and Biochemical Parameters Among Patients With Non Alcoholic Fatty Liver Disease (NAFLD)
por: Hashemi kani, Ali, et al.
Publicado: (2013)

HBV Subgenotypes D1, D2, D-del! Are ‘Old‘ Genotyping Methods Interpreted Correctly?
por: Amini-Bavil-Olyaee, Samad, et al.
Publicado: (2013)

Hepatitis Monthly, an International Journal in the Field of Hepatology
por: Rezaee-Zavareh, Mohammad Saeid, et al.
Publicado: (2016)

Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol
por: Jazayeri-Tehrani, Seyed Ali, et al.
Publicado: (2017)

Inter-observer and Intra-observer Agreement in Pathological Evaluation of Non-alcoholic Fatty Liver Disease Suspected Liver Biopsies
por: Pournik, Omid, et al.
Publicado: (2014)

Liver Mitochondrial DNA Copy Number and Deletion Levels May Contribute to Nonalcoholic Fatty Liver Disease Susceptibility
por: Kamfar, Sharareh, et al.
Publicado: (2016)

Hepatitis B Immune Globulin in Liver Transplantation Prophylaxis: An Update
por: Dindoost, Payam, et al.
Publicado: (2012)

Green cardamom increases Sirtuin-1 and reduces inflammation in overweight or obese patients with non-alcoholic fatty liver disease: a double-blind randomized placebo-controlled clinical trial
por: Daneshi-Maskooni, Milad, et al.
Publicado: (2018)

Autoimmune Hepatitis in Iran: What We Know, What We Don’t Know and Requirements for Better Management
por: Shafiei, Mostafa, et al.
Publicado: (2012)

Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial
por: Jazayeri-Tehrani, Seyed Ali, et al.
Publicado: (2019)

The Key Role of Non-governmental Organizations (NGOs) Activities in Viral Hepatitis Elimination Programs
por: Padami, Farzaneh, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_r86l7a0hl18g2s15jo9abdspbi